SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-015564
Filing Date
2022-05-27
Accepted
2022-05-27 16:03:13
Documents
13
Period of Report
2022-05-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20220523.htm   iXBRL 8-K 33800
5 ardx-20220523_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-22-015564.txt   180166

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20220523.xsd EX-101.SCH 1899
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20220523_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20220523_pre.xml EX-101.PRE 13044
7 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20220523_htm.xml XML 11233
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 22977260
SIC: 2834 Pharmaceutical Preparations